Vascularized Bone Grafts for Treatment of Scaphoid Nonunion
Launched by ASSIUT UNIVERSITY · Apr 28, 2022
Trial Information
Current as of May 21, 2025
Unknown status
Keywords
ClinConnect Summary
The scaphoid is the most commonly fractured carpal bone accounting for 60% of fractures. A number of case series have identified a 10%-15% nonunion rate. Scaphoid nonunion refers to a spectrum of failed healing, each of which requires a tailored approach.
Subsequent to non-union, degenerative changes with the formation of cysts, bony resorption with loss of bone stock and the development of apex dorsal angulation or the humpback deformity may occur leading to scaphoid non-union advanced collapse (SNAC) of the wrist and the formation of a proximal pole which extends with the lunate.
This h...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- All Patients will be included if they met the following criteria:
- • Age: all patient more than 18 years up to 55 years
- • Fracture: nonunion and a vascular necrosis proved by MRI (Herbert stage I or II) , humpback deformity, Proximal pole fracture, cystic degeneration, failed previous surgery (K wire, Herbert, plate distal radius)
- • Pain: persistent disabling pain and tenderness at wrist joint due to scaphoid nonunion.
- • patient: both sex will included, both handiness, good bone quality.
- Exclusion Criteria:
- • Commuted Other carpus fractures
- • Nonunion less than 3 months
- • Radio-carpal Arthritis or instability
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Mohamed Kotb, M.D
Study Director
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials